News

GFSAY

IPO Report: Veracyte (VCYT)

Francis Gaskins | Equities.com |

Veracyte ($VCYT) reduces unnecessary surgeries through molecular cytology diagnostics. Eight other operating company IPOs are scheduled for this week. The full IPO calendar can be found at



Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum